Description
Biomarkers In The Era Of Immunotherapy: Lessons Learned From Lung, Bladder And Kidney Cancer Special,
- You cannot add another "Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer" to your cart. View cart
Article: Biomarkers In The Era Of Immunotherapy: Lessons Learned From Lung, Bladder And Kidney Cancer Special,
€3.03
